SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001213900-21-007634
Filing Date
2021-02-09
Accepted
2021-02-09 10:20:29
Documents
1
Group Members
PONTIFAX 5 G.P. L.P.PONTIFAX MANAGEMENT 4 G.P. (2015) LTD.TOMER KARIV

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13G ea134989-13ga1nussbaum_89bio.htm SC 13G/A 161922
  Complete submission text file 0001213900-21-007634.txt   163321
Mailing Address C/O KITE PHARMA, INC. 2225 COLORADO AVENUE SANTA MONICA CA 90404
Business Address
Nussbaum Ran (Filed by) CIK: 0001609805 (see all company filings)

Type: SC 13G/A

Mailing Address 535 MISSION STREET 14TH FLOOR SAN FRANCISCO CA 94105
Business Address 535 MISSION STREET 14TH FLOOR SAN FRANCISCO CA 94105 4155004614
89bio, Inc. (Subject) CIK: 0001785173 (see all company filings)

IRS No.: 831114349 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91200 | Film No.: 21604459
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences